PAPZIMEOS Approval Call
Aug 18, 2025 at 8:00 AM EDT
Precigen conference call provided additional details regarding the FDA approval of PAPZIMEOS (zopapogene imadenovec-drba), including key aspects of the label and commercialization.
Supporting Materials
View Presentation 2.8 MB